- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02267421
Effects of Home Based Exercise Therapy in Early Cirrhosis
An 8 Week Randomized Controlled Trial Assessing Home Exercise Therapy in Early Cirrhosis
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Alberta
-
Edmonton, Alberta, Canada, T6G2B1
- University of Alberta, Mazankowski Heart Institute
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Age >18 and less than or equal to 70 years Liver Cirrhosis Child Pugh Class A or B If required, primary or secondary Variceal prophylaxis in place
Exclusion Criteria:
- Post-liver transplantation Hepatocellular carcinoma beyond transplant criteria Active non-hepatocellular carcinoma malignancy Significant cardiac disease Hemoglobin (<80 g/L) Oxygen saturation at rest <95% Known myopathy Chronic renal failure on dialysis Physical impairment making it impossible to ride an exercise bike or treadmill Orthopedic abnormality preventing exercise training HIV infection Patient unwilling to consent to study Child Pugh class C
Study Plan
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
EXPERIMENTAL: Home based aerobic exercise
Home based aerobic exercise on cycle ergometer.
Three times per week, 30-60 minutes per session.
|
|
|
NO_INTERVENTION: Usual Care group
These patients will continue with their normal activities of daily living and will not be provided with equipment or coaching for home based exercise during the study period .
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Change in peak exercise pulmonary oxygen uptake (VO2peak).
Time Frame: Baseline (day 1) and Study End (8 weeks)
|
Baseline (day 1) and Study End (8 weeks)
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Change in muscle mass as measured by thigh ultrasound
Time Frame: Baseline (day 1) and Study end (8 weeks)
|
Baseline (day 1) and Study end (8 weeks)
|
|
Change in quality of life - Chronic Liver Disease Questionnaire
Time Frame: Baseline (Day 1) and Study completion (8 weeks)
|
Baseline (Day 1) and Study completion (8 weeks)
|
|
Change in muscle oxygen extraction and consumption as measured by MRI
Time Frame: Baseline (day 1) and study completion (8 weeks)
|
Baseline (day 1) and study completion (8 weeks)
|
Collaborators and Investigators
Sponsor
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ESTIMATE)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- CKPTMHLivCirHomeTraining
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.